Low-Titre GAD Antibody-Associated Late-Onset Cerebellar Ataxia with a Significant Clinical Response to Intravenous Immunoglobulin Treatment.
Cerebellum. 2017 Aug;16(4):868-871. doi: 10.1007/s12311-017-0851-z.
Cerebellum. 2017.
PMID: 28321713